Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study

Figure 2

Changes in BMI and bone mineral density as induced by two different ARV modalities. BMI regularly increased with time, a significant 5% rise was recorded only in the PI group. Following a 21-month ART (M21) an average 3% reduction of lumbar spine BMD was observed. Bone mineral loss was different between treatments: drop in L2-L4 density was 1.5% the NNRTI group and 4% in the PI group.

Back to article page